首页> 外文期刊>International Journal of Nanomedicine >Synergistic Nanocomposites of Different Antibiotics Coupled with Green Synthesized Chitosan-Based Silver Nanoparticles: Characterization, Antibacterial, in vivo Toxicological and Biodistribution Studies
【24h】

Synergistic Nanocomposites of Different Antibiotics Coupled with Green Synthesized Chitosan-Based Silver Nanoparticles: Characterization, Antibacterial, in vivo Toxicological and Biodistribution Studies

机译:不同抗生素的协同纳米复合材料与绿色合成壳聚糖基银纳米颗粒:表征,抗菌,体内毒理学和生物分布研究

获取原文
           

摘要

Purpose: The present study reports chitosan functionalized green synthesized CS-AgNPs, conjugated with amoxicillin (AMX), cefixime (CEF), and levofloxacin (LVX) for safe and enhanced antibacterial activity. Methods: The CS-AgNPs and conjugates CS-AgNPs AMX CS-AgNPs CEF, and CS-AgNPs LVX were characterized by UV–Vis, FTIR, SEM, TEM, EDX spectroscopy. The size distribution and zeta potential were measured using the dynamic light scattering (DLS) technique. The interaction between CS-AgNPs and antibiotic molecules was also investigated using UV–Vis spectroscopy at the concentrations of 5, 50, 500, and 5000 μM for each antibiotic. Antibacterial activity and synergism were assessed by the Fractional Inhibitory Concentration (FIC) index. The mechanism for synergistic activity was investigated by the detection of hydroxyl species based on the chemiluminescence of luminol. The biocompatibility index (BI) was calculated from IC 50 using the HeLa cell line. In vivo toxicity and tissue distribution of silver ions were evaluated on Sprague Dawley rats. Physical interactions of antibiotics and significant (P 0.05) antibacterial activity were observed after loading on CS-AgNPs surfaces. Results: The spherical shape nanocomposites of CS-AgNPs with different antibiotics were prepared with mean size ranges of 80– 120 nm. IC 50 of antibiotics-conjugated CS-AgNPs decreased compared to CS-AgNPs. The biocompatibility (BI) index showed that antibiotics-conjugated CS-AgNPs have high antibacterial potential and low toxicity. Highly significant (P 0.005) increase in the generation of hydroxyl species indicated the radical scavenging mechanism for synergistic activity of CS-AgNPs after combined with different antibiotics. Biochemical analysis and histopathological examinations confirmed low toxicity with minor hepatotoxicity at higher doses. After oral administration, extensive distribution of Ag ion was observed in spleen and liver. Conclusion: The study demonstrates positive attributes of antibiotics-conjugated CS-AgNPs, as a promising antibacterial agent with low toxicity.
机译:目的:本研究报告壳聚糖官能化绿色合成的Cs-agnps,与阿莫西林(AMX),Cefimmime(CEF)和左氧氟沙星(LVX)缀合,用于安全和增强的抗菌活性。方法:通过UV-Vis,FTIR,SEM,TEM,EDX光谱,CS-AgNP和CS-AgNPS和缀合物CS-AgNPS AMX CS-AgNPS CEF和CS-AgNPS LVX。使用动态光散射(DLS)技术测量尺寸分布和Zeta电位。在每种抗生素的5,50,500和5000μm的浓度下使用UV-Vis光谱研究Cs-AgNP和抗生素分子之间的相互作用。通过分数抑制浓度(FIC)指数评估抗菌活性和协同作用。通过基于鲁米诺化学发光的羟基物质检测协同活性的机制。使用HeLa细胞系从IC 50计算生物相容性指数(BI)。在Sprague Dawley大鼠评估银离子的体内毒性和组织分布。在Cs-AgNPS表面上加载后观察到抗生素和显着(P <0.05)抗菌活性的物理相互作用。结果:用平均尺寸范围为80-20nm,制备具有不同抗生素的Cs-agnps的球形纳米复合材料。与Cs-agnps相比,IC 50的抗生素缀合的Cs-agnps降低。生物相容性(BI)指数显示抗生素 - 缀合的Cs-agnps具有高抗菌潜力和低毒性。高显着(P <0.005)羟基物质的产生增加表明,与不同抗生素相结合后Cs-agnps协同活性的自由基清除机制。生物化学分析和组织病理学检查证实了在较高剂量下对次要肝毒性的低毒性。在口服给药后,在脾脏和肝脏中观察到Ag离子的广泛分布。结论:该研究表明,抗生素缀合的Cs-agnps阳性属性,作为具有低毒性的有前途的抗菌剂。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号